Irish Government appoints Xeinadin Board member on Commission of Taxation and Welfare

Irish Government appoints Xeinadin Group Board member on Commission of Taxation and Welfare

Date:

Category:

Share this article:

Sandra Clarke, Board Director of Xeinadin, the Ireland and UK-based business advisory and accountancy firm, has been appointed as a member on the Government of Ireland’s Commission on Taxation and Welfare.

With over 30 years of experience in the accountancy & taxation sector, Sandra is a Chartered Tax Adviser and specialises in particular on taxation within the SME sector. Being a council member of the Irish Tax Institute, Sandra has contributed to numerous tax policy submissions to the Department of Finance and similarly being self-employed and responsible for over 20 employees, she is well positioned to support in analysing and making recommendations for the future tax and welfare system. Sandra is a Board Director for Xeinadin and Managing Partner of BCC Accountants, a member firm of the firm.

The Commision on Taxation and Welfare, established under the Department of Finance, will independently consider how best the taxation and welfare systems can support economic activity and promote increased employment and prosperity across Ireland. The 14 member committee has been carefully selected to bring a mix of direct experience and knowledge of several areas relevant to the Commission’s work, including taxation, welfare, economics, legal and broader civil society.

Sandra Clarke on appointment commented:
“I’m privileged to be a part of the Commission on Taxation and Welfare and working with the Chairperson Professor Niamh Moloney and the other selected members. We have an important job to do on behalf of the Irish economy and I’m proud to be able to play a part in that. I look forward to the challenges and discussions towards achieving a balanced outcome for the Commissions report in July 2022.”

Media Enquiries
[email protected]
020 3757 6767
Ian Morris, Jessica Hodson Walker

Latest blogs

Nothing was found here.

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

If you opt for acceptance, we will place all cookies. If you opt for rejection, we will only place functional and analytical cookies. You can adjust your preferences at a later time.

Accept Reject More options

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

Functional cookies
Arrow down

Functional cookies are essential for the proper functioning of our website. They allow us to enable basic functions such as page navigation and access to secure areas. These cookies do not collect personal information and cannot be disabled.

Analytical cookies
Arrow down

Analytical cookies help us gain insight into how visitors use our website. We collect anonymised data about page interactions and navigation, enabling us to continuously improve our site.

Marketing cookies
Arrow down

Marketing cookies are used to track visitors when they visit different websites. The goal is to display relevant advertisements to the individual user. By allowing these cookies, you help us show you relevant content and offers.

Accept all Save

Name

Subtitle
Developer
Location
They are focussed on creating a future-focused and relationship-driven culture, that keeps its promises to you, our team members, and partners.
Xeinadin